Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study
Open Access
- 8 January 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 54 (1), 61-68
- https://doi.org/10.1016/j.jmii.2020.12.005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of eosinophil in peripheral blood of patients with COVID‐19 and its clinical significanceJournal of Clinical Laboratory Analysis, 2020
- Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control studyEClinicalMedicine, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020Eurosurveillance, 2020
- Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19Journal of Korean Medical Science, 2020
- Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based studyPLoS Medicine, 2018
- Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapyInternational Journal of Infectious Diseases, 2017
- Valeur de l’éosinopénie dans le diagnostic des syndromes inflammatoires : un « vieux » marqueur revisitéLa Revue de Médecine Interne, 2003
- Experimental observations on the eosinopenia induced by acute infection.1971